drug · vaccine component
Coronavirus Disease 2019 (COVID-19) vaccine
Phase 3updated 3mo agoby $SNY Sanofi🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 6Vaccine component drug with a maximum clinical stage of Approval, with an approval for covid-19.
targets
Spike glycoprotein
all catalysts(0)
nothing on the calendar yet
Trials studying Coronavirus Disease 2019 (COVID-19) vaccine
- phase1Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
- —COVID-19 Vaccines International Pregnancy Exposure Registry
- EP1Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
- —A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
- phase1A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- phase4Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
- phase2Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
- phase2SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
News(10)
- BioNTech vets get $25M seed funding for virtual cancer surveillance startupBioNTech’s former chief strategy officer Ryan Richardson had a front seat to the creation of a Covid vaccine, and then helped orchestrate BioNTech’s return to its pursuit of new cancer therapies. I…endpoints · 7h ago
- FDA approves Moderna’s mRNA flu vaccineThe clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.biopharma_dive · 4d ago
- BioNTech cuts sales forecast on slumping demand for COVID-19 vaccineLower vaccine demand across every market and more acute pressures in Germany led BioNTech to lower the midpoint of its sales outlook by almost 20%.biospace · 6d ago
- BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotechBioNTech’s leadership transition was announced earlier this year, with CEO Ugur Sahin and CMO Özlem Türeci leaving to start a new mRNA company. Guido Oelkers of Swedish Orphan Biovitrum AB will tak…biospace · 7d ago
- STAT+: BioNTech names Guido Oelkers its new CEOGuido Oelkers will take over as the new CEO of BioNTech, replacing company cofounder Ugur Sahin.stat · 7d ago
- After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA companyOne of the most closely watched vacancies in biopharma has now been filled, with Sobi CEO Guido Oelkers, Ph.D., moving across to take up the top job at mRNA pioneer BioNTech.fiercebiotech · 7d ago
- STAT+: Trump promised redemption for troops who refused Covid shots. A year later, many are still waitingVeterans who want to rejoin the military are often bogged down in bureaucratic red tape.stat · 18d ago
- Agenus surges on study pivot; Apnimed lines up an IPOAgenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA decision date.biopharma_dive · 28d ago
- Nominee for key federal health role has a history of questioning vaccinesSean Kaufman's views on vaccines may put him at odds with Sen. Bill Cassidy during next week's confirmation hearing.stat · 1mo ago
- HHS advances plan to pay out Covid-19 vaccine injury claimsA newly proposed HHS rule would establish a compensation mechanism for people who claim they were injured by Covid-19 vaccines, as a key panel that oversees broader vaccine injury payments remains…endpoints · 1mo ago
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that